Wells Fargo’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-7,985
| Closed | -$7K | – | 7369 |
|
|
2019
Q4 | $7K | Sell |
7,985
-100,143
| -93% | -$76.9K | ﹤0.01% | 5994 |
|
|
2019
Q3 | $61K | Sell |
108,128
-242
| -0.2% | -$130 | ﹤0.01% | 5504 |
|
|
2019
Q2 | $56K | Sell |
108,370
-50,400
| -32% | -$25.2K | ﹤0.01% | 5512 |
|
|
2019
Q1 | $72K | Buy |
158,770
+1,993
| +1% | +$930 | ﹤0.01% | 5239 |
|
|
2018
Q4 | $75K | Sell |
156,777
-3,538
| -2% | -$1.76K | ﹤0.01% | 5408 |
|
|
2018
Q3 | $85K | Buy |
160,315
+995
| +0.6% | +$533 | ﹤0.01% | 5420 |
|
|
2018
Q2 | $79K | Sell |
159,320
-414
| -0.3% | -$193 | ﹤0.01% | 5468 |
|
|
2018
Q1 | $67K | Buy |
159,734
+565
| +0.4% | +$227 | ﹤0.01% | 5468 |
|
|
2017
Q4 | $60K | Sell |
159,169
-20
| -0% | -$8 | ﹤0.01% | 5496 |
|
|
2017
Q3 | $57K | Sell |
159,189
-235
| -0.1% | -$87 | ﹤0.01% | 5424 |
|
|
2017
Q2 | $61K | Buy |
159,424
+1,563
| +1% | +$638 | ﹤0.01% | 5342 |
|
|
2017
Q1 | $71K | Buy |
157,861
+99,855
| +172% | +$43.9K | ﹤0.01% | 5339 |
|
|
2016
Q4 | $22K | Sell |
58,006
-1,295
| -2% | -$438 | ﹤0.01% | 5610 |
|
|
2016
Q3 | $16K | Sell |
59,301
-1,683
| -3% | -$426 | ﹤0.01% | 5670 |
|
|
2016
Q2 | $14K | Sell |
60,984
-1,417
| -2% | -$244 | ﹤0.01% | 5597 |
|
|
2016
Q1 | $7K | Buy |
62,401
+554
| +0.9% | +$60 | ﹤0.01% | 5820 |
|
|
2015
Q4 | $7K | Sell |
61,847
-13,098
| -17% | -$1.85K | ﹤0.01% | 5834 |
|
|
2015
Q3 | $14K | Sell |
74,945
-14,975
| -17% | -$5.09K | ﹤0.01% | 5647 |
|
|
2015
Q2 | $63K | Sell |
89,920
-1,283
| -1% | -$888 | ﹤0.01% | 5255 |
|
|
2015
Q1 | $62K | Sell |
91,203
-122
| -0.1% | -$85 | ﹤0.01% | 4931 |
|
|
2014
Q4 | $72K | Sell |
91,325
-2,518
| -3% | -$1.72K | ﹤0.01% | 4883 |
|
|
2014
Q3 | $44K | Buy |
93,843
+26
| +0% | +$13 | ﹤0.01% | 4987 |
|
|
2014
Q2 | $47K | Sell |
93,817
-1,017
| -1% | -$492 | ﹤0.01% | 4997 |
|
|
2014
Q1 | $29K | Sell |
94,834
-3,882
| -4% | -$1.44K | ﹤0.01% | 5122 |
|
|
2013
Q4 | $34K | Buy |
98,716
+27,262
| +38% | +$32.9K | ﹤0.01% | 4864 |
|
|
2013
Q3 | $144K | Sell |
71,454
-76
| -0.1% | -$145 | ﹤0.01% | 4343 |
|
|
2013
Q2 | $136K | Buy |
+71,530
| New | +$126K | ﹤0.01% | 4294 |
|
Wells Fargo's GCVRZ Position: Q1 2020 in Review
Wells Fargo sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 7,985 shares — an estimated $7K sold.
Wells Fargo first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $144K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Wells Fargo reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Wells Fargo sold 7,985 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $7K.
- Wells Fargo first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Wells Fargo's Sanofi Contingent Value Rights position peaked at $144K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Wells Fargo's 13F filing for Q1 2020, filed 14 May 2020.